Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Alimentary Pharmacology & Therapeutics|March 1, 2017
Visceral adiposity predicts post-operative Crohn's disease recurrenceD Q Holt, G T Moore, B J G Strauss, et al.Pulmonary Pharmacology & Therapeutics|August 16, 2011
24-hour bronchodilation following a single dose of the novel β(2)-agonist olodaterol in COPDJ A van Noord, J J Smeets, B M Drenth, et al.Nucleosides & Nucleotides|August 26, 1998
Use of 5-nitroindole-2'-deoxyribose-5'-triphosphate for labelling and detection of oligonucleotidesC L Smith, A C Simmonds, A L Hamilton, et al.British Journal of Cancer|June 12, 2014
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanomaM S Carlino, L E Haydu, H Kakavand, et al.The ISME Journal|May 26, 2021
Novel strain-level resolution of Crohn's disease mucosa-associated microbiota via an ex vivo combination of microbe culture and metagenomic sequencingJ J Teh, E M Berendsen, E C Hoedt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycleA L Hamilton, J P Eder, A C Pavlick, et al.Gut Microbes|February 28, 2023
Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn's disease. The ENIGMA studyJ J Jimenez Loayza, S Kang, L Schooth, et al.Alimentary Pharmacology & Therapeutics|August 29, 2015
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisP De Cruz, M A Kamm, A L Hamilton, et al.Pageof 2